# A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese

> **NCT02786069** · PHASE1 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 16 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Propionyl L-carnitine Hydrochloride

## Key facts

- **NCT ID:** NCT02786069
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-11
- **Final completion:** 2016-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786069, "A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02786069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*